What’s the current market cap for ASR Nederland stock?

ASR Nederland (ASRNL) has a market cap of €13B as of May 29, 2026.

What is the P/E ratio for ASR Nederland stock?

The price to earnings (P/E) ratio for ASR Nederland (ASRNL) stock is 29.94 as of May 29, 2026.

Does ASR Nederland stock pay dividends?

Yes, the ASR Nederland (ASRNL) stock pays dividends to shareholders. As of May 29, 2026, the dividend rate is €3.41 and the yield is 5.27%. ASR Nederland has a payout ratio of 121.72% on a trailing twelve-month basis.

When is the next ASR Nederland dividend payment date?

The next ASR Nederland (ASRNL) dividend payment date is unconfirmed.

What is the beta indicator for ASR Nederland?

ASR Nederland (ASRNL) has a beta rating of 0.51. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy ASR Nederland stock | €ASRNL Share Price

05:30

09:10

12:45

16:25

20:00

About ASR Nederland

ASR Nederland, operating under the ticker ASRNL, is a major insurance company based in the Netherlands. Founded in 1720, the company provides a comprehensive range of financial products and services including non-life insurance, life insurance, and investment products. ASR Nederland serves both individual consumers and business clients, distinguishing itself in the sector through its long history and broad market presence.

Ticker

€ASRNL

Sector

Finance

Primary listing

AEX

Employees

7,245

Headquarters

Utrecht, Netherlands

Website

www.asrnl.com

ASR Nederland Metrics

BasicAdvanced

€13bn

29.94

€2.16

0.51

€3.41

5.27%

What the Analysts think about ASR Nederland

Analyst ratings (Buy, Hold, Sell) for ASR Nederland stock.

Bulls say / Bears say

Solvency II ratio improved to 218% at end-2025 from 198% in 2024, supported by €1.32 billion in organic capital generation and the approval of a Partial Internal Model for life operations (Reuters)

Operating result rose 11.9% to €1.64 billion in FY25, and operating return on equity increased to 14.1%, surpassing the company's 12% target (Reuters)

ASR proposed a total dividend of €3.41 per share (up 9.3% YoY) and announced a €175 million share buyback programme to be completed by May 19, 2026, reaffirming its commitment to shareholder returns (Reuters)

Net profit attributable to equity holders dropped 42.8% to €548 million in FY25, mainly due to negative valuation adjustments in investments and finance caused by interest-rate movements and one-off items (Reuters)

Non-life operating result declined 6.1% to €474 million in FY25, with the combined ratio deteriorating to 92.2% from 90.9%, as reserve increases in group disability insurance outweighed gains in P&C claims (Reuters)

Operating expenses increased 4% to €1.47 billion, driven by the consolidation of HumanTotalCare and higher salary costs from a new labour agreement, squeezing margins (Reuters)

Data summarised monthly by Lightyear AI. Last updated on 24 May 2026.

ASR Nederland Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

ASR Nederland Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Market data provided by CBOE Europe and Deutsche Börse.

Buy €ASRNL

€

Capital at risk

Extended hours trading

Upcoming events

No upcoming events

Bulls say / Bears say

Solvency II ratio improved to 218% at end-2025 from 198% in 2024, supported by €1.32 billion in organic capital generation and the approval of a Partial Internal Model for life operations (Reuters)

Operating result rose 11.9% to €1.64 billion in FY25, and operating return on equity increased to 14.1%, surpassing the company's 12% target (Reuters)

Operating expenses increased 4% to €1.47 billion, driven by the consolidation of HumanTotalCare and higher salary costs from a new labour agreement, squeezing margins (Reuters)

Data summarised monthly by Lightyear AI. Last updated on 24 May 2026.

About ASR Nederland

Ticker

Primary listing

Employees

ASR Nederland Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

What the Analysts think about ASR Nederland

Analyst Ratings

Bulls say / Bears say

ASR Nederland Financial Performance

Income Statement

ASR Nederland Earnings Performance

Earnings per share (EPS)

Buy €ASRNL

Upcoming events

No upcoming events

Lightyear

Legal

Work with us

Bulls say / Bears say

ASR Nederland/€ASRNL

About ASR Nederland

Ticker

Primary listing

Employees

ASR Nederland Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

What the Analysts think about ASR Nederland

Analyst Ratings

Bulls say / Bears say

ASR Nederland Financial Performance

Income Statement

ASR Nederland Earnings Performance

Earnings per share (EPS)

Buy €ASRNL

Upcoming events

No upcoming events

What’s the current market cap for ASR Nederland stock?

What is the P/E ratio for ASR Nederland stock?

Does ASR Nederland stock pay dividends?

When is the next ASR Nederland dividend payment date?

What is the beta indicator for ASR Nederland?

Bulls say / Bears say